Ford Motor Stock Rises After Earnings, But Momentum May Not Last — Positive
F MarketBeat — May 07, 2025Ford Motor NYSE: F reported earnings after the market closed on May 5. The automaker's report was better than expected, and the stock jumped nearly 3% the day after the report.

Super Micro's Q3: Down But Not Out, This AI Phoenix Should Rise — Positive
SMCI Seeking Alpha — May 07, 2025Super Micro's Q3 revenue dip to $4.6B, attributed to customer pause before Blackwell GPU adoption, masks strong underlying AI demand and sets the stage for a rebound. Despite inventory write-downs hitting Q3 EPS ($0.31), strategic clearing for Blackwell and new AMD solutions position SMCI for future margin recovery and growth. Innovative DCBBS and advanced DLC-2 liquid cooling are key differentiators, promising significant TCO savings for customers and a strong competitive moat for SMCI.

Levi & Korsinsky Notifies Ultra Clean Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UCTT — Neutral
UCTT Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Ultra Clean Holdings, Inc. (NASDAQ:UCTT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ultra-clean-holdings-inc-lawsuit-submission-form?prid=147246&wire=1 or contact Joseph E. Levi, Esq.

SUPN STOCK ALERT: Levi & Korsinsky Notifies Supernus Pharmaceuticals, Inc. Investors of an Ongoing Investigation — Neutral
SUPN Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals, Inc.") (NASDAQ:SUPN) concerning possible violations of federal securities laws. On February 19, 2025, The company announced that its Phase 2b study of SPN-820 for treatment-resistant depression failed to meet its primary endpoint, showing no significant improvement over placebo.

ATTENTION AAPL SHAREHOLDERS: Investors who Lost Money on Apple Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation — Neutral
AAPL Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Apple Inc. ("Apple Inc.") (NASDAQ:AAPL) concerning possible violations of federal securities laws. Apple announced its upcoming release of the new iPhone 16 and 16 Plus models on June 10, 2024.

Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 - ZBIO — Neutral
ZBIO Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=147249&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on Civitas Resources, Inc. (CIVI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
CIVI Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=147261&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Fluence Energy, Inc. Lawsuit - FLNC — Neutral
FLNC Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=147262&wire=1 or contact Joseph E. Levi, Esq.

Class Action Filed Against Avis Budget Group, Inc. (CAR) - June 24, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
CAR Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=147263&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of SoundHound AI, Inc. (SOUN) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
SOUN Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your SoundHound AI, Inc. (NASDAQ:SOUN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/soundhound-ai-inc-lawsuit-submission-form?prid=147247&wire=1 or contact Joseph E. Levi, Esq.

Shareholders of Perpetua Resources Corp. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - PPTA — Neutral
PPTA Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=147248&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that Lost Money on Telix Pharmaceuticals Limited (TLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - TLX — Neutral
TLX Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:TLX) concerning possible violations of federal securities laws. On April 28, 2025, Telix issued a press release announcing that the FDA issued a Complete Response Letter denying approval of Telix's New Drug Application for TLX101-CDx ("Pixclara").

Eli Lilly Being Investigated on Behalf of Eli Lilly and Company Investors. Contact Levi & Korsinsky For Details — Neutral
LLY Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eli Lilly and Company ("Eli Lilly") (NYSE:LLY) concerning possible violations of federal securities laws. On May 1, 2025, Eli Lilly issued a press release reporting first quarter 2025 results and reaffirming guidance.

JACK ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Jack in the Box Inc. investment — Neutral
JACK Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Jack in the Box Inc. ("Jack in the Box") (NASDAQ:JACK) concerning possible violations of federal securities laws. On April 23, 2025, Jack in the Box issued a press release announcing plans to close 150 to 200 "underperforming locations" and explore a sale of its Del Taco brand.

TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ: CIGI) (TSX: CIGI) (“Colliers”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted a notice of its intention to make a normal course issuer bid (the “NCIB”) with respect to its outstanding subordinate voting shares (the “Subordinate Voting Shares”).

Like A Pro: 2 Wide-Moat Dividend Machines Built To Beat The Market — Positive
HII LOW Seeking Alpha — May 07, 2025Beating Wall Street isn't impossible, especially if you stick to time-tested strategies. I focus on wide-moat stocks with strong fundamentals and smart capital allocation. With the rise of low-cost ETFs and passive investing, staying disciplined is more critical than ever. I follow principles that have worked for the best in the game. In my article, I highlight two high-quality businesses I believe can thrive in any environment, growing income, compounding returns, and helping us sleep well at night.

URZ3 Energy Welcomes Mr. Paul Goranson to the Board of Directors and Announces Private Placement — Neutral
UUUU TheNewswire — May 07, 2025Vancouver, B.C. - TheNewswire - May 7, 2025 – URZ3 Energy Corp. (TSX.V: URZ) (OTCQB: URZEF) (“ URZ3 ” or the “ Company ”) is pleased to announce Mr. Paul Goranson has joined URZ3 as a member of the Board of Directors. Additionally, the Company announces a non-brokered placement of up to $1,100,000. "We are excited to welcome Paul to URZ3 Energy both personally and professionally. The majority of our team have known Mr. Goranson for decades and worked with him in the past. From an industry standpoint, his knowledge of the uranium sector is invaluable including his direct practical …

ATTENTION Xponential Fitness, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights — Neutral
XPOF Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Xponential Fitness, Inc. ("Xponential Fitness") (NYSE:XPOF) concerning possible violations of federal securities laws. Xponential issued a press release on March 13, 2025, announcing the Company's fourth quarter and full year financial results.

AUSTIN, Texas , May 7, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2025. Please click the included PDF link to access the full earnings press release.

Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update — Neutral
CGTX GlobeNewsWire — May 07, 2025- End-of-Phase 2 meeting with FDA requested for Alzheimer's disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's role supporting retinal cell health - PURCHASE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update.
